Drug Profile
VMD 30283
Alternative Names: VMD30283Latest Information Update: 21 Sep 2015
Price :
$50
*
At a glance
- Originator VM Discovery
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Myocardial infarction
Most Recent Events
- 21 Sep 2015 No recent reports on development identified - Phase-I/II for Myocardial infarction in USA (unspecified route)
- 21 Feb 2007 VMD 30283 is available for partnering or licensing worldwide (http://www.vmdiscovery.com/)
- 21 Feb 2007 Phase-I/II clinical trials in Myocardial infarction in USA (unspecified route)